Funded Tech Companies

Modus Therapeutics

Modus Therapeutics is a biopharmaceutical tech venture, based in Stockholm. Financial backing was provided by Rosetta Partners and private investors.

Company Overview

Company Name
Modus Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Sankt Eriksgatan 117
Stockholm, SE-113 43
Sweden
Email Address

Company Background Information

Overview
Modus Therapeutics is a Swedish drug development company developing sevuparin -- a novel drug to treat people suffering from Sickle Cell Disease -- a painful, inherited blood disorder affecting millions of people around the globe.
Profile
Modus Therapeutics LinkedIn Company Profile
Social Media
Modus Therapeutics Company Twitter Account
Company News
Modus Therapeutics News
Facebook
Modus Therapeutics on Facebook
YouTube
Modus Therapeutics on YouTube
Last Transaction
2/23/2017

Financing History

Date
Type
Amount
Venture Equity
$3,566,252


Management Team

Title
Name
Email & Social
Chief Executive Officer
Ellen Donnelly
  Ellen Donnelly LinkedIn Profile  Ellen Donnelly Twitter Account  Ellen Donnelly News  Ellen Donnelly on Facebook
Chief Scientific Officer
Mats Wahlgren
  Mats Wahlgren LinkedIn Profile  Mats Wahlgren Twitter Account  Mats Wahlgren News  Mats Wahlgren on Facebook


Company Investors

  • Rosetta Partners

 

 

 

Browse more funded tech companies:

Modus Real Estate | ModusBox

 

Share this article

 


About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary